Associate Professor; Director of the CLL and Richter Transformation Program
Lineberger Comprehensive Cancer Center, University of North Carolina
Chapel Hill, North Carolina, United States
Deborah Stephens, DO is the Director of the Chronic Lymphocytic Leukemia (CLL) Program and the CLL/Lymphoma Research Group and an Associate Professor at the Lineberger Comprehensive Cancer Center at the University of North Carolina in Chapel Hill, North Carolina. Dr. Stephens leads a subspecialty CLL-focused clinic. Her primary research interests include developing targeted therapies for CLL and lymphoma, studying therapy resistance, and developing supportive therapies for CLL complications. She is principal investigator on multiple clinical trials including the international chair of the SWOG S1925 EVOLVE CLL Study. She leads the CLL Subcommittee within the SWOG Group. Dr. Stephens has served on the CLL NCCN Guidelines Panel and the Medical Advisory Board of the CLL Society.
Novel BCR Pathway Targeting Agents
Monday, September 15, 2025
08:30 - 08:45 CEST
